We next asked whether EDI as a measure of microenvironmental heterogeneity correlated with cancer hallmarks that have previously been correlated with cancer progression, mutagenesis, and heterogeneity, including APOBEC3B expression [24], genomic instability [25,26], and TP53 mutation [27,28]. This evidence concerns the gene TP53 and cancer.